|
|
|
|
LEADER |
00000cam a2200000Ii 4500 |
001 |
SCIDIR_on1057725696 |
003 |
OCoLC |
005 |
20231120010320.0 |
006 |
m o d |
007 |
cr cnu|||unuuu |
008 |
181024s2019 enk ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d OPELS
|d OCLCF
|d MERER
|d D6H
|d CNO
|d OCLCQ
|d DKU
|d OCLCO
|d OCL
|d OCLCO
|d OCLCA
|d S2H
|d OCLCO
|d YDX
|d OCLCQ
|d OCLCO
|
020 |
|
|
|a 9780128140406
|q (electronic bk.)
|
020 |
|
|
|a 0128140402
|q (electronic bk.)
|
020 |
|
|
|z 9780128140390
|
035 |
|
|
|a (OCoLC)1057725696
|
050 |
|
4 |
|a RC271.I45
|b R49 2019eb
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.99/406
|2 23
|
100 |
1 |
|
|a Rezaei, Nima,
|e author.
|
245 |
1 |
0 |
|a Vaccines for cancer immunotherapy :
|b a comprehensive evidence-based review on current status and future perspectives /
|c Nima Rezaei, Mahsa Keshavarz-Fathi.
|
264 |
|
1 |
|a London :
|b Academic Press, an imprint of Elsevier,
|c [2019]
|
264 |
|
4 |
|c �2019
|
300 |
|
|
|a 1 online resource (xiii, 183 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Online resource ; title from PDF title page (EBSCO, viewed October 25, 2018).
|
504 |
|
|
|a Includes bibliographical references and index.
|
520 |
|
|
|a Therapeutic cancer vaccines represent a type of active cancer immunotherapy. Clinicians, scientists, and researchers working on cancer treatment require evidence-based and up-to-date resources relating to therapeutic cancer vaccines. Vaccines for Cancer Immunotherapy provides a reference for cancer treatment for clinicians and presents a well-organized resource for determining high-potential research areas. The book considers that this promising modality can be made more feasible as a treatment for cancer. Chapters cover cancer immunology, general approaches to cancer immunotherapy, vaccines, tumor antigens, the strategy of allogeneic and autologous cancer vaccines, personalized vaccines, whole-tumor antigen vaccines, protein and peptide vaccines, dendritic cell vaccines, genetic vaccines, candidate cancers for vaccination, obstacles to developing therapeutic cancer vaccines, combination therapy, future perspectives and concluding remarks on therapeutic cancer vaccines.
|
505 |
0 |
|
|a Cancer immunology -- Immunotherapeutic approaches to cancer -- Vaccines, adjuvants, and delivery systems -- Tumor antigens -- Strategy of allogeneic and autologous cancer vaccines -- Personalized cancer vaccine -- Whole tumor cell vaccine for cancer -- Peptide and protein vaccines for cancer -- Immune cell vaccine for cancer -- Genetic vaccine for cancer -- Candidate cancers for vaccination -- Obstacles in the development of therapeutic cancer vaccines -- Combination therapy : cancer vaccines and other therapeutics -- Concluding remarks and future perspectives on therapeutic cancer vaccines.
|
650 |
|
0 |
|a Cancer
|x Immunotherapy.
|
650 |
|
0 |
|a Vaccines.
|
650 |
|
0 |
|a Evidence-based medicine.
|
650 |
|
2 |
|a Neoplasms
|x therapy
|0 (DNLM)D009369Q000628
|
650 |
|
2 |
|a Immunotherapy
|x methods
|0 (DNLM)D007167Q000379
|
650 |
|
2 |
|a Neoplasms
|x immunology
|0 (DNLM)D009369Q000276
|
650 |
|
2 |
|a Vaccines
|0 (DNLM)D014612
|
650 |
|
6 |
|a Cancer
|x Immunoth�erapie.
|0 (CaQQLa)201-0168739
|
650 |
|
6 |
|a Vaccins.
|0 (CaQQLa)201-0018490
|
650 |
|
6 |
|a M�edecine factuelle.
|0 (CaQQLa)201-0320438
|
650 |
|
7 |
|a HEALTH & FITNESS / Diseases / General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL / Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL / Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL / Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL / Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Evidence-based medicine
|2 fast
|0 (OCoLC)fst00917247
|
650 |
|
7 |
|a Cancer
|x Immunotherapy
|2 fast
|0 (OCoLC)fst00845386
|
650 |
|
7 |
|a Vaccines
|2 fast
|0 (OCoLC)fst01163573
|
700 |
1 |
|
|a Keshavarz-Fathi, Mahsa,
|e author.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128140390
|z Texto completo
|